Telemedicine Management of Hypertension for Hypertension

Phase-Based Progress Estimates
Wake Forest University Health Sciences, Winston-Salem, NC
Telemedicine Management of Hypertension - Behavioral
All Sexes
What conditions do you have?

Study Summary

Explore barriers, facilitators, acceptability, feasibility, and fidelity of the telemedicine management of hypertension intervention

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Hypertension

Study Objectives

5 Primary · 0 Secondary · Reporting Duration: Month 3

Month 3
Acceptability of Intervention (AIM)
Appropriateness of Intervention (IAM)
Cost Estimates
Feasibility of Intervention (FIM)
Fidelity of Intervention/implementation

Trial Safety

Safety Progress

1 of 3

Other trials for Hypertension

Trial Design

1 Treatment Group

Telemedicine Management of Hypertension
1 of 1
Experimental Treatment

20 Total Participants · 1 Treatment Group

Primary Treatment: Telemedicine Management of Hypertension · No Placebo Group · N/A

Telemedicine Management of Hypertension
Experimental Group · 1 Intervention: Telemedicine Management of Hypertension · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: month 3
Closest Location: Wake Forest University Health Sciences · Winston-Salem, NC
2008First Recorded Clinical Trial
10 TrialsResearching Hypertension
423 CompletedClinical Trials

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,100 Previous Clinical Trials
1,129,005 Total Patients Enrolled
18 Trials studying Hypertension
39,978 Patients Enrolled for Hypertension
Yashashwi Pokharel, MDPrincipal InvestigatorWake Forest University Health Sciences

Eligibility Criteria

Age 18+ · All Participants · 6 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have a systolic blood pressure of 140 or more mmHg on two or more clinic visits.
You possess a smart phone.
You must be able to speak and read English.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.